wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35657842-ECDE8896-3C14-4964-B5FF-DAFCD9470960
Q35657842-ECDE8896-3C14-4964-B5FF-DAFCD9470960
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35657842-ECDE8896-3C14-4964-B5FF-DAFCD9470960
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer
P2860
Q35657842-ECDE8896-3C14-4964-B5FF-DAFCD9470960
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35657842-ECDE8896-3C14-4964-B5FF-DAFCD9470960
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d517e6fefd3ff012c62e9c9188f80d64d5fdad2
P2860
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group